EN DE
Watch Numinus Wellness Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Numinus Wellness Inc (NUMIF) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Numinus Wellness Inc stock $0.02, price $0.02, upside +25.4%, quality 29 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in Canada

NW Numinus Wellness Inc logo Thin data Nov 10, 2026

Numinus Wellness Inc

NUMIF · US
Fairly valued, weak quality

The stock costs 20% less than our calculation considers fair.

Highly profitable · 102.1% net margin (TTM)
Even on cautious assumptions the value is 20% above the price ($0.0183).
Fair value $0.0191 · Fairly valued
Mixed Growth (revenue 5y +107.8 %/yr in CAD)
Negative equity (buybacks among others)
Mixed vs. peers (3/7)
Quality 29/100
Negative free cash flow
Narrow moat 43/100
Thin data
Estimate
Watch Numinus Wellness Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.7582 $0.0060 Fair Value $0.0191 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0060 – $0.7582 · fair‑value band $0.0183 – $0.0198 · the $0.0152 price screens below the $0.0191 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Numinus Wellness in your weekly email

Every Wednesday you see whether Numinus Wellness is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments.

Show moreShow less

It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts.

Numinus Wellness Inc. is headquartered in Vancouver, Canada.

Stock analysis

Numinus Wellness Inc (NUMIF) currently trades at $0.0152, while our estimate is $0.0191, so the stock looks roughly fairly valued today (gap 20.3%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.0183 (bear) to $0.0198 (bull), the price of $0.0152 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 29/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Numinus Wellness Inc reported revenue of C$4.2M in FY2024 versus C$881K in FY2020, a compound +47.5%/yr. Reported net income was −C$19.6M in FY2024.

Key figures

Market cap $6.4M Micro · P/S ratio 0.94 · EPS (TTM) $−0.0300 · Return on equity −858% · Return on assets (EBIT) −84.3% (5-year average) · Operating margin −14.9% · Revenue (TTM) C$6.9M · Revenue growth (YoY) −10.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (medium confidence).

What moves the price

The share trades about 70% below its 52-week high and 153% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at 25%, NUMIF screens cheaper than that median.

Fair Value

Bear $0.0183 Fair Value $0.0191 Bull $0.0198
Price $0.0152 · Upside +25.4%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 29/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 8
How much profit the company makes from its sales and capital
Quality Growth 51
Are margins and returns getting better?
Cashflow 9
Do the profits arrive as real cash?
Financial strength 37
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 11
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+11.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+40.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+107.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−5,892.3% (2019) → −280.9% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
not computed

Watch NUMIF, get fair value alerts →

Compare Numinus Wellness Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 246 stocks

Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 29 · Bottom 25%
Fair Value upside +25.7% · Above median
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −182.4% · Bottom 25%
Net margin (12 months) 102.1% · Top 25%
Operating margin (12 months) −14.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −10.8% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 1.33× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)68 · sector 33
FUTURE (revenue growth)0 · sector 33
PAST (return on equity)0 · sector 31
HEALTH (low debt)0 · sector 90
DIVIDEND (yield)0 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $22.74 $46.55 +105% vs NUMIF
Aier Eye Hospital Group 300015 ¥8.85 ¥10.88 +23% vs NUMIF
DaVita Inc DVA $179.28 $218.90 +22% vs NUMIF
HCA Healthcare, Inc HCA $504.42 $547.34 +9% vs NUMIF
Tenet Healthcare Corporation THC $290.27 $279.20 −4% vs NUMIF
The Ensign Group ENSG $185.09 $140.09 −24% vs NUMIF
Encompass Health Corporation EHC $142.51 $94.81 −33% vs NUMIF
Fresenius SE FRE €53.47 €34.77 −35% vs NUMIF
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,550 ₹5,234 −39% vs NUMIF
Dr. Sulaiman Al Habib Medical Services Group 4013 214.70 SAR 109.45 SAR −49% vs NUMIF

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Numinus Wellness Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Numinus Wellness Inc Fair Value". https://www.fairvalue-calculator.com/stock/NUMIF

Frequently asked questions

Is Numinus Wellness Inc (NUMIF) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.0191 versus a price of $0.0152, about +25% upside (fairly valued).
What is the fair value of NUMIF?
Our estimate for Numinus Wellness Inc is $0.0191 (as of Nov 10, 2026), built from audited fundamentals. The current price: $0.0152.
What is the quality score of NUMIF?
Numinus Wellness Inc has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Numinus Wellness Inc (NUMIF)?
Our calculated price target is the estimate of $0.0191 (as of Nov 10, 2026). Cautious scenario $0.0183, optimistic scenario $0.0198. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Numinus Wellness Inc stock forecast for 2026?
Our estimate puts fair value at $0.0191, about +25% upside versus a price of $0.0152 (fairly valued). Cautious scenario $0.0183, optimistic scenario $0.0198. The calculation is refreshed regularly with new filings.
What is the revenue of Numinus Wellness Inc (NUMIF)?
Numinus Wellness Inc reported trailing-twelve-month revenue of about C$6.9M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Numinus Wellness Inc (NUMIF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Numinus Wellness Inc it is $0.0191 per share (as of Nov 10, 2026), against a price of $0.0152.
Is Numinus Wellness Inc stock overvalued or undervalued in 2026?
As of Nov 10, 2026, NUMIF trades below its calculated fair value: price $0.0152, fair value $0.0191, a gap of about +25% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NUMIF?
No. The price is what the market pays today ($0.0152); the fair value is what the company's own numbers justify ($0.0191). For Numinus Wellness Inc the two are $0.0039 per share apart. That gap is exactly why we show both numbers side by side.
How much is Numinus Wellness Inc worth?
The market values Numinus Wellness Inc at about $6.4M (market capitalisation, as of Nov 10, 2026). Per share that is $0.0152; our models calculate a fair value of $0.0191 per share.
What do the bullish and bearish scenarios say about NUMIF?
Our models span a range for Numinus Wellness Inc: cautious scenario $0.0183, base $0.0191, optimistic $0.0198 per share (as of Nov 10, 2026, price $0.0152). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Numinus Wellness Inc (NUMIF)?
Balance-sheet figures for Numinus Wellness Inc (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 29/100, which measures business quality independently of the share price.
How far is NUMIF from its 52-week high?
Numinus Wellness Inc trades at $0.0152, about 70% below its 52-week high of $0.0500 and 153% above the low of $0.0060 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0191 is for.
Which stocks are comparable to Numinus Wellness Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Numinus Wellness Inc stock attractive at the current price?
The data as of Nov 10, 2026: price $0.0152, calculated fair value $0.0191 (+25%), Quality Score 29/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Numinus Wellness Inc currently trades 20% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Numinus Wellness Inc (NUMIF)?
The closing price on Nov 10, 2026 was $0.0152. Our estimate is $0.0191, about +25% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Numinus Wellness Inc right now?
The price is below even our cautious bear case ($0.0183). The market is more pessimistic than our downside scenario. The models converge in a tight band ($0.0183 to $0.0198), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Numinus Wellness Inc

How large is the market capitalisation of Numinus Wellness Inc (NUMIF)?
The market capitalisation of Numinus Wellness Inc is $6.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Numinus Wellness Inc (NUMIF)?
The price-to-sales ratio of Numinus Wellness Inc is 0.94 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Numinus Wellness Inc (NUMIF)?
Earnings per share at Numinus Wellness Inc are $−0.0300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Numinus Wellness Inc (NUMIF)?
The return on equity (ROE) of Numinus Wellness Inc is −858% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Numinus Wellness Inc (NUMIF)?
On an EBIT basis the return on assets of Numinus Wellness Inc is −84.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Numinus Wellness Inc (NUMIF)?
The operating margin of Numinus Wellness Inc is −14.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Numinus Wellness Inc (NUMIF)?
Revenue at Numinus Wellness Inc is growing −10.8% versus a year earlier (3y avg +40.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Numinus Wellness Inc (NUMIF) generate?
The free cash flow of Numinus Wellness Inc is −C$17.5M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Numinus Wellness Inc in the live analysis

One click puts Numinus Wellness Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.